By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – OptiGene today announced an agreement to license Eiken Chemical's LAMP gene amplification technology.

Separately, Eiken this week said that it also is licensing the technology to the UK Veterinary Laboratories Agency.

As part of its agreement, OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.